| April 2004 | ||||||
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | |
| Mar May | ||||||
For more search options, please see the Advanced search form and the section of the User's Guide, Tips for Searching PULSE.
C H A N N E L S
• PULSE Home
Page
•
EXECUTIVE
EDITION
•
US News
•
Canada
News
•
UK News
•
New
Zealand News
•
Consumer
Advocacy
•
Health
Care Systems
•
Managed
Care/Medicaid
•
Co-occurring
Disorders
•
Clinical
studies
•
Pharmaceutical
News
•
Criminal
Justice Systems
•
Legislative
News
U S E R ' S G
U I D E
About
PULSE
PULSE Channels
Archives
Adding comments
Using the # link
Items that require registration
PULSE syndication
Tips for Searching PULSE
E M A I L S
U B S C R I P T I O N S
For WEEKLY summaries
of PULSE postings, see the weekly
email subscription form.
For DAILY mailings (powered
by Bloglet), please enter your e-mail address below:
PULSE ANNUAL No. 2
January 2003
Recent
Trends, Challenges and Issues in Funding Public Mental Health Services
in the US
March 2002
PULSE ANNUAL No. 1
October 2001
PULSE is powered by
Radio Userland.
© Bill Davis, 2000-2003.
![]()
High-Dose Cyclic Antidepressants Linked With Risk of Sudden Cardiac Death
Reuters Health story at Medscape - "The risk of sudden cardiac death is not increased with selective serotonin reuptake inhibitor (SSRI) antidepressants, or tricyclic and other related cyclic antidepressants (TCAs) in doses less than 100 mg, according to results of a study published in the March issue of Clinical Pharmacology and Therapeutics. However, there appears to be an association between higher doses of TCAs and increased relative risk." "med"
Developments in the Treatment of Cannabis Use Disorder
Article from Current Opinion in Psychiatry at Medscape that describes recent developments in the treatment of cannabis abuse and dependence in the general and special populations - "There is a paucity of research into pharmacological and psychological interventions for cannabis use disorder. There are no accepted pharmacotherapies available. Whereas relatively brief cognitive-behavioural therapy has the strongest evidence of success for adults with cannabis dependence, among adolescents involved in the juvenile justice system and those with severe, persistent mental illness, longer and more intensive therapies provided by interdisciplinary teams may be required..." [Viewing Medscape resources requires registration, which is free].![]()